SCHEMBL18580296

SCHEMBL18580296

COc1cccc(COC[C@@H](C)N)c1

nearest known ligand 0.68

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.68
IDO1 P14902 2/20 0.60
AGXT P21549 2/20 0.60
MAOB P27338 5/20 0.53
TACR1 P25103 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
AOC3 Q16853 1/20 0.46
SLC6A4 P31645 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18580298 1.00 TAAR1 (0.68) TAAR1IDO1AGXTMAOBTACR1
SCHEMBL14731903 0.83 TAAR1 (0.67) TAAR1IDO1AGXTMAOBAOC3
SCHEMBL3768643 0.82 IDO1 (0.71) TAAR1IDO1AGXTMAOBAOC3
SCHEMBL12093573 0.82 IDO1 (0.57) TAAR1IDO1AGXTMAOBMEN1
SCHEMBL7600364 0.81 TACR1 (0.46) TAAR1MAOBTACR1SLC6A4
(S)-M-Methoxyamphetamine SCHEMBL3293027 0.81 TAAR1 (1.00) TAAR1IDO1AGXTSLC6A4
(S)-M-Methoxyamphetamine SCHEMBL11461072 0.81 TAAR1 (1.00) TAAR1IDO1AGXTSLC6A4
(S)-M-Methoxyamphetamine SCHEMBL30813013 0.81 TAAR1 (1.00) TAAR1IDO1AGXTSLC6A4
(S)-M-Methoxyamphetamine SCHEMBL269071 0.81 TAAR1 (1.00) TAAR1IDO1AGXTSLC6A4
SCHEMBL31462271 0.80 TDP1 (0.57) TAAR1IDO1AGXTMAOBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12195446-B2 Heteroaryl compounds and their use as therapeutic drugs DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-01-14 US disclosed
US-20230002353-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG A SOCIO HOLDINGS CO LTD (KR) 2023-01-05 US disclosed
CN-108368083-B Heteroaryl compounds and their use as therapeutic agents 东亚首希控股股份有限公司 2022-02-01 CN disclosed
US-10947215-B2 Heteroaryl compounds and their use as therapeutic drugs DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2021-03-16 US disclosed
EP-3344613-B1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG A SOCIO HOLDINGS CO LTD (KR) 2020-03-04 EP disclosed
US-20190119252-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2019-04-25 US disclosed
US-10125118-B2 Heteroaryl compounds and their use as therapeutic drugs DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2018-11-13 US disclosed
EP-3344613-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS Dong-A Socio Holdings Co., Ltd. (KR) 2018-07-11 EP disclosed
US-20170355690-A9 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2017-12-14 US disclosed
US-20170066742-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG-A SOCIO HOLDINGS CO LTD (KR) 2017-03-09 US disclosed
WO-2017039331-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2017-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355690-A9 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885
US-10947215-B2 Heteroaryl compounds and their use as therapeutic drugs MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885
US-12195446-B2 Heteroaryl compounds and their use as therapeutic drugs MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885
US-10125118-B2 Heteroaryl compounds and their use as therapeutic drugs MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885
US-20190119252-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885
US-20230002353-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885
US-20170066742-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS MERTK, ERBB2, SRC TAAR1 2485/4885IDO1 2290/4885AGXT 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.